The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Javier Blas on twitter:
EUROPEAN ENERGY CRUNCH: European natural gas prices hitting fresh record highs, with UK NBP and Dutch TTF up >13% on the day to the equivalent to ~$38 per million Btu. In turn, European electricity prices are jumping this morning too |
To put the rally in European natural gas prices into context, at current prices gas is trading above $215 per barrel of oil equivalent. Yes, that's not a typo: triple-digit starting with a two
Here is the court listing. It's a Lady Judge. Court 9 - sitting at 10:30 am HER HONOUR JUDGE TAYLOR, HON. RECORDER OF WESTMINSTER (1) For Sentence S20190022 LUFKIN David CLONM SERIOUS FRAUD OFFICE *PAPER FILE* CASE LINKED TO, Order made under Contempt of Court Act 1981 S20210027 LUFKIN David CLONM SERIOUS FRAUD OFFICE DEFENDANT TO ATTEND: ALL COUNSEL IN PERSON, Order made under Contempt of Court Act 1981 For Plea T20217220 PETROFAC LTD CLONM SERIOUS FRAUD OFFICE ALL PARTIES TO ATTEND, Order made under Contempt of Court Act 1981
Catenae is an intellectual property client of Z/Yen using ChainZy for its OnSite products and will provide expertise and Catenae’s own propriety technology which is currently deployed across the Sporting, Man-Guarding and Facilities Management sectors.
About Z/Yen Group
Z/Yen was founded in 1994 to promote societal advance through better finance and technology. Z/Yen has built its practice around a core of high-powered project managers, supported by experienced technical specialists so that clients get expertise they need, rather than just resources available. The firm is headquartered in London, but Z/Yen is committed to the ‘virtual office’ concept and is an intense user of technology in order to improve flexibility and benefit staff. Z/Yen has 25 full-time-equivalent staff and over 300 associate experts. Z/Yen people share significantly in the benefits of success and Z/Yen seeks to develop a supportive environment in which professionals from a variety of disciplines can flourish.
Consortium members
Other members of the consortium are:-
fm2x, a specialist software provider working with Z/Yen for over 25 years providing secure systems to the Cabinet Office and running youthinmind’s systems, handling over 15 million clinical assessments per year.SI Units, a data science company of young researchers specialising in bespoke projects connecting interdisciplinary expertise providing novel forecasts, using machine learning, artificial intelligence, data science and physics.
There is no guarantee that the Cov-ID product will be finalised nor enter the commercialisation stage, nor that in the event that it is commercialised, that the commercial terms will be favourable to the Company.
We are part of a consortium led by Z Yen and have already been involved in a pilot.
https://www.branduk.net/tag/zyen-group-ltd/
https: //cov-id.io
From the wording on the website it appears the app is already in action.
https://www.catenaeinnovation.com/government
Market research showed a topical treatment similar to MED3000 had an estimated market potential of $560M as prescription-only and an estimated $660M+ as an over-the-counter (OTC) product with 70% potential incremental sales.
Assuming MED3000 could eventually switch to over the counter, the market research firm Ipsos used its validated healthcare forecasting model to forecast peak OTC annual sales for MED3000 in key countries worldwide of more than US$650 million. Importantly, Ipsos forecasts that 70% of these potential OTC sales would be incremental to the prescription category. The key findings of the market research showed that the respondents believed that the product, once approved, would be highly differentiated from existing products.